论文部分内容阅读
目的对糖皮质激素应用于哮喘急性发作患者治疗中的效果进行评价。方法选择2014年3月-2016年3月收治的哮喘急性发作患者80例为研究对象,随机分为观察组和对照组,每组40例。对照组给予特布他林治疗,观察组给予糖皮质激素布地奈德治疗。疗程结束后,比较2组的治疗效果及安全性。结果观察组总有效率为95.00%,高于对照组的77.50%;不良反应发生率为7.50%,低于对照组的25.00%,2组比较差异均有统计学意义(P<0.05)。结论糖皮质激素在哮喘急性发作患者治疗中的应用,能够有效缓解患者的哮喘症状,效果显著。
Objective To evaluate the efficacy of glucocorticoids in the treatment of acute asthma attacks. Methods Eighty patients with acute exacerbation of asthma admitted from March 2014 to March 2016 were selected as study subjects and randomly divided into observation group and control group, 40 cases in each group. The control group was given terbutaline treatment, and the observation group was given glucocorticoid budesonide. After the end of treatment, the treatment effect and safety of the two groups were compared. Results The total effective rate in the observation group was 95.00%, higher than 77.50% in the control group. The incidence of adverse reactions was 7.50%, which was lower than that in the control group (25.00%). There was significant difference between the two groups (P <0.05). Conclusion The application of glucocorticoids in the treatment of acute asthma patients can effectively relieve the symptoms of asthma in patients with significant effect.